BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26908122)

  • 1. DNM2 mutations in Chinese Han patients with centronuclear myopathy.
    Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C
    Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational and clinical spectrum of centronuclear myopathy in 9 cases and a literature review of Chinese patients.
    Wang Q; Yu M; Xie Z; Liu J; Wang Q; Lv H; Zhang W; Yuan Y; Wang Z
    Neurol Sci; 2022 Apr; 43(4):2803-2811. PubMed ID: 34595679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
    Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
    J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.
    Zhao Y; Zhao Z; Shen H; Bing Q; Hu J
    Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.
    Liewluck T; Lovell TL; Bite AV; Engel AG
    Neuromuscul Disord; 2010 Dec; 20(12):801-4. PubMed ID: 20817456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
    Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
    Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China.
    Chen T; Pu C; Wang Q; Liu J; Mao Y; Shi Q
    Neurol Sci; 2015 May; 36(5):735-41. PubMed ID: 25501959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
    Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
    Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myotonia in DNM2-related centronuclear myopathy.
    Dabby R; Sadeh M; Gilad R; Jurkat-Rott K; Lehmann-Horn F; Leshinsky-Silver E
    J Neural Transm (Vienna); 2014 May; 121(5):549-53. PubMed ID: 24366529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.
    Böhm J; Biancalana V; Dechene ET; Bitoun M; Pierson CR; Schaefer E; Karasoy H; Dempsey MA; Klein F; Dondaine N; Kretz C; Haumesser N; Poirson C; Toussaint A; Greenleaf RS; Barger MA; Mahoney LJ; Kang PB; Zanoteli E; Vissing J; Witting N; Echaniz-Laguna A; Wallgren-Pettersson C; Dowling J; Merlini L; Oldfors A; Bomme Ousager L; Melki J; Krause A; Jern C; Oliveira AS; Petit F; Jacquette A; Chaussenot A; Mowat D; Leheup B; Cristofano M; Poza Aldea JJ; Michel F; Furby A; Llona JE; Van Coster R; Bertini E; Urtizberea JA; Drouin-Garraud V; Béroud C; Prudhon B; Bedford M; Mathews K; Erby LA; Smith SA; Roggenbuck J; Crowe CA; Brennan Spitale A; Johal SC; Amato AA; Demmer LA; Jonas J; Darras BT; Bird TD; Laurino M; Welt SI; Trotter C; Guicheney P; Das S; Mandel JL; Beggs AH; Laporte J
    Hum Mutat; 2012 Jun; 33(6):949-59. PubMed ID: 22396310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
    Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
    Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare case of centronuclear myopathy with
    Aghbolaghi AG; Lechpammer M
    Autops Case Rep; 2017; 7(2):43-48. PubMed ID: 28740838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing dynamin 2 (DNM2) rescues
    Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
    Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
    Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult centronuclear myopathies: A hospital-based study.
    Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
    Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic changes in the extraocular muscle in centronuclear myopathy with a Dynamin 2 mutation.
    Hanna N; Bouhenni R; Gupta B; Abu-Amero KK; Wollmann R; Edward DP
    Ophthalmic Genet; 2013; 34(1-2):83-6. PubMed ID: 22924779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
    Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
    Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.
    Susman RD; Quijano-Roy S; Yang N; Webster R; Clarke NF; Dowling J; Kennerson M; Nicholson G; Biancalana V; Ilkovski B; Flanigan KM; Arbuckle S; Malladi C; Robinson P; Vucic S; Mayer M; Romero NB; Urtizberea JA; García-Bragado F; Guicheney P; Bitoun M; Carlier RY; North KN
    Neuromuscul Disord; 2010 Apr; 20(4):229-37. PubMed ID: 20227276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamin 2-related centronuclear myopathy: clinical, histological and genetic aspects of further patients and review of the literature.
    Jeub M; Bitoun M; Guicheney P; Kappes-Horn K; Strach K; Druschky KF; Weis J; Fischer D
    Clin Neuropathol; 2008; 27(6):430-8. PubMed ID: 19130742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dog model for centronuclear myopathy carrying the most common DNM2 mutation.
    Böhm J; Barthélémy I; Landwerlin C; Blanchard-Gutton N; Relaix F; Blot S; Laporte J; Tiret L
    Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35244154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.